Vitamin D3 up-regulating protein 1 (VDUP1) antisense DNA, regulates tumorigenicity and melanogenesis of murine melanoma cells via regulating the expression of fas ligand and reactive oxygen species
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Song, H | - |
dc.contributor.author | Cho, D | - |
dc.contributor.author | Jeon, JH | - |
dc.contributor.author | Han, SH | - |
dc.contributor.author | Hur, DY | - |
dc.contributor.author | Kim, YS | - |
dc.contributor.author | Choi, I | - |
dc.date.available | 2021-02-22T16:17:41Z | - |
dc.date.issued | 2003-05 | - |
dc.identifier.issn | 0165-2478 | - |
dc.identifier.issn | 1879-0542 | - |
dc.identifier.uri | https://scholarworks.sookmyung.ac.kr/handle/2020.sw.sookmyung/16194 | - |
dc.description.abstract | The expression of vitamin D-3 up-regulating protein-1 (VDUP1) was up-regulated by 1alpha,25-dihydroxyvitamin D-3 (VD3) treatment in B16 mouse melanoma cells. The functional effect of VDUP1 on B16F10 melanoma cells was demonstrated by reduction of Fas ligand and CD44 expression in cells transfected with VDUP1 antisense cDNA. Furthermore, intracellular reactive oxygen species level and cell proliferation were decreased in antisense transfectants compared with those in vector controls. However, melanin synthesis was up-regulated in antisense transfectants. In addition, VDUP1 antisense transfectants showed an increased susceptibility to natural killer (NK) cells in vitro. When VDUP1 antisense transfectants were implanted into syngeneic mice, significant reduction of tumor cell growth was observed with the infiltrate of T cells and NK cells in tumor area. Taken together, these results demonstrate that VDUP1 has critical physiological roles and can be a novel therapeutic target for melanoma. (C) 2003 Elsevier Science B.V. All rights reserved. | - |
dc.format.extent | 13 | - |
dc.language | 영어 | - |
dc.language.iso | ENG | - |
dc.publisher | ELSEVIER SCIENCE BV | - |
dc.title | Vitamin D3 up-regulating protein 1 (VDUP1) antisense DNA, regulates tumorigenicity and melanogenesis of murine melanoma cells via regulating the expression of fas ligand and reactive oxygen species | - |
dc.type | Article | - |
dc.publisher.location | 네델란드 | - |
dc.identifier.doi | 10.1016/S0165-2478(03)00024-5 | - |
dc.identifier.scopusid | 2-s2.0-0037403578 | - |
dc.identifier.wosid | 000182759500003 | - |
dc.identifier.bibliographicCitation | IMMUNOLOGY LETTERS, v.86, no.3, pp 235 - 247 | - |
dc.citation.title | IMMUNOLOGY LETTERS | - |
dc.citation.volume | 86 | - |
dc.citation.number | 3 | - |
dc.citation.startPage | 235 | - |
dc.citation.endPage | 247 | - |
dc.type.docType | Article | - |
dc.description.isOpenAccess | N | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.relation.journalResearchArea | Immunology | - |
dc.relation.journalWebOfScienceCategory | Immunology | - |
dc.subject.keywordPlus | NF-KAPPA-B | - |
dc.subject.keywordPlus | 1,25-DIHYDROXYVITAMIN D-3 | - |
dc.subject.keywordPlus | THIOREDOXIN REDUCTASE | - |
dc.subject.keywordPlus | IN-VITRO | - |
dc.subject.keywordPlus | HYDROGEN-PEROXIDE | - |
dc.subject.keywordPlus | DEPENDENT PATHWAY | - |
dc.subject.keywordPlus | SUPEROXIDE ANION | - |
dc.subject.keywordPlus | OXIDATIVE STRESS | - |
dc.subject.keywordPlus | HYALURONIC-ACID | - |
dc.subject.keywordPlus | DOWN-REGULATION | - |
dc.subject.keywordAuthor | VDUP1 | - |
dc.subject.keywordAuthor | melanoma cells | - |
dc.subject.keywordAuthor | ROS | - |
dc.subject.keywordAuthor | FasL | - |
dc.subject.keywordAuthor | NK cells | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
Sookmyung Women's University. Cheongpa-ro 47-gil 100 (Cheongpa-dong 2ga), Yongsan-gu, Seoul, 04310, Korea02-710-9127
Copyright©Sookmyung Women's University. All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.